Searched over 200M research papers
10 papers analyzed
These studies suggest that low ferritin and iron saturation are indicators of iron deficiency and associated health risks, particularly in hemodialysis patients and those with chronic conditions.
20 papers analyzed
Ferritin and transferrin saturation (TSAT) are critical markers used to assess iron status in the body. Ferritin is a protein that stores iron, while TSAT measures the percentage of transferrin (a blood protein that binds iron) that is saturated with iron. Low ferritin and low TSAT levels can indicate iron deficiency, which is a common issue in various populations, including those with chronic diseases and the elderly.
In hemodialysis patients, managing iron levels is crucial due to the frequent occurrence of anemia. The DRIVE study demonstrated that intravenous ferric gluconate significantly improves hemoglobin levels in anemic hemodialysis patients with high ferritin (500-1200 ng/ml) and low TSAT (≤25%) compared to no iron treatment. This suggests that intravenous iron can be beneficial even when ferritin levels are high, provided TSAT is low.
High ferritin levels combined with low TSAT in hemodialysis patients often indicate inflammation rather than iron overload. Research has shown that ferritin levels above 500 ng/ml, especially with TSAT below 25%, are strongly associated with inflammatory markers like C-reactive protein and IL-6. This inflammation can complicate the interpretation of iron status and the management of anemia.
Low TSAT and high ferritin levels are significant predictors of adverse outcomes in hemodialysis patients. Studies have found that patients with these iron profiles have an increased risk of cerebrovascular and cardiovascular diseases and higher mortality rates. This highlights the importance of careful monitoring and management of iron levels to mitigate these risks.
In normal subjects, ferritin levels below 10 ng/ml are associated with low TSAT and iron-deficient erythropoiesis. This correlation is also observed in blood donors, where low ferritin levels indicate depleted iron stores, especially in frequent donors. In children, low MCH and TSAT are more reliable indicators of iron deficiency anemia than ferritin alone.
Given the limitations of ferritin and TSAT, especially in the presence of inflammation, alternative markers are being explored. These include reticulocyte hemoglobin content, percentage of hypochromic red cells, and soluble transferrin receptor, which may provide more accurate assessments of iron status in complex cases.
Low ferritin and iron saturation are critical indicators of iron deficiency, but their interpretation can be challenging, especially in the presence of inflammation. Intravenous iron therapy can be effective in improving anemia in hemodialysis patients with high ferritin and low TSAT. However, careful monitoring is essential due to the associated risks of cardiovascular disease and mortality. Alternative markers may offer more reliable assessments in certain populations, enhancing the management of iron deficiency.
Most relevant research papers on this topic